Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
– First approved allogeneic cell therapy product globally for the treatment of CLI Developed by Stempeutics over a period of twelve years, breakthrough treatment designed